'Money well spent today means less money spent tomorrow' on HIV/AIDS

This Lancet Infectious Diseases editorial responds to the Global HIV/AIDS Response 2011 progress report (.pdf) launched by WHO, UNICEF, and UNAIDS on November 30, writing that the report "contains much good news on treatment and prevention, but the gains made by past efforts are jeopardized by the ongoing global financial crisis and dwindling funds."

"Economic uncertainty threatens the future of people who still do not have access to treatment, many of whom do not even know that they are infected with HIV," the editorial states, adding, "Social and political marginalization of certain groups means that programs to reach them might be most at risk in the face of funding cuts, but in many cases these groups are now the stronghold of the epidemic and key in the fight against it." It concludes, "Universal access to treatment by 2015 is certainly an ambitious goal, but a realistic one if donor governments can maintain their commitment and if recipient nations adopt strategic and sustainable approaches in their HIV/AIDS programs. Money well spent today means less money spent tomorrow" (January 2012).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug